Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori: A randomized clinical trial

Table 2 Incidence of adverse effects among the study groups

Analysis	QT-10	QT-14	OST-14	P value1
ITT	39%	42.7%	24.7%	0.03
PP	45.1%	49.5%	31.3%	0.01

¹P value of χ² test.

ITT: Intention to treat; PP: Per-protocol.